Physician profile
Michael G Wallace
NPI 1689615346
$6,278.80
in general payments reported to CMS, 2019-2025
15 companies · $624 in 2025
The $624 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $259 · 2021: $497 · 2022: $1,264 · 2023: $1,885 · 2024: $979 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,215 · Travel and Lodging: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,214.50 |
| Travel and Lodging | $1,273.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,702.42 | 2021-2024 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Coopervision INC. | $954.93 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Biotissue Holdings INC. | $702.91 | 2024 | |
| Allergan, INC. | $624.71 | 2019-2022 | |
| Lombart Brothers, INC. | $457.97 | 2019-2024 | Opd-III |
| Sight Sciences, INC. | $399.34 | 2021-2023 | Tearcare System |
| Lkc Technologies, INC. | $310.84 | 2023-2025 | |
| Optos, INC. | $193.43 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $180.79 | 2022 | |
| Bausch & Lomb Americas INC. | $171.55 | 2023-2025 | Infuse, Alden Scleral Zenlens, Alden Soft Irregular |
| Johnson & Johnson Vision Care, INC. | $140.93 | 2019-2023 | Acuvue |
| Optovue, INC. | $138.93 | 2021 | |
| Carl Zeiss Meditec, INC. | $120.04 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $107.13 | 2019 | |
| Abbvie INC. | $72.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.